Effectiveness and safety of a GLP-1 agonist in obese patients with inflammatory bowel disease

1. Belinchón, C.R.
2. Martínez-Lozano, H.
3. Moreno, C.S.
4. Castillo, D.H.
5. Chicharro, P.L.
6. Ocampo, P.F.
7. Marín-Jiménez, I.
8. Lesmes, I.B.
9. Menchén, L.